开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=1078015, encodeId=05d510e80156f, content=偏重的研究方向：Meta;血液 经验分享：状态从under review变为Decision in process后多长时间有结果啊，好紧张啊，有没有前辈能回答一下，谢谢<a href='/topic/show?id=fa4e5501ec2' target=_blank style='color:#2F92EE;'>#投稿状态#</a><a href='/topic/show?id=5b8055014a9' target=_blank style='color:#2F92EE;'>#投稿#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=55017, encryptionId=fa4e5501ec2, topicName=投稿状态), TopicDto(id=55014, encryptionId=5b8055014a9, topicName=投稿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Wed Dec 08 09:39:59 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513535, encodeId=9214513535ab, content=Required Reviews Completed状态一天今天变成Decision in process,不知结局如何，继续求好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a671625636, createdName=nina2014, createdTime=Wed Jul 15 13:48:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513451, encodeId=8351513451f7, content=请问各位大神，under review 12天后变成 decision in process, 现在已经持续5天了（中间一个周末双休），这状态要持续几天呀？是凶是吉啊？卤煮现在甚是焦躁哇。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05041614884, createdName=ashley1012118, createdTime=Sun Jul 12 23:42:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089503, encodeId=10d7108950371, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089504, encodeId=f947108950474, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973948, encodeId=46b39e39482d, content=请问这个期刊可以共同通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Wed Jun 16 01:58:03 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054187, encodeId=107a105418e73, content=with editor后变成decision in process状态已经8天了，是不是凉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9d85585451, createdName=邪, createdTime=Thu Sep 23 16:30:51 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058774, encodeId=05181058e7452, content=这个杂志的审稿费怎么交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Sat Oct 09 00:04:23 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799866, encodeId=0b00e9986634, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：使用新药治疗9例临床报道，一审3周，大修，第一审稿人提了8个问题，第二审稿人3个问题，一个月修回，2周后接收。审稿人比较客气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Thu Jun 25 22:19:22 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803723, encodeId=13fa803e234c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床研究被BJH，PBC拒稿，投该杂志一个月后小修，录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Tue Jul 21 18:53:14 CST 2020, time=2020-07-21, status=1, ipAttribution=)]

2021-12-08 1801fe6feam

偏重的研究方向：Meta;血液
经验分享：状态从under review变为Decision in process后多长时间有结果啊，好紧张啊，有没有前辈能回答一下，谢谢#投稿状态##投稿#

142 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1078015, encodeId=05d510e80156f, content=偏重的研究方向：Meta;血液 经验分享：状态从under review变为Decision in process后多长时间有结果啊，好紧张啊，有没有前辈能回答一下，谢谢<a href='/topic/show?id=fa4e5501ec2' target=_blank style='color:#2F92EE;'>#投稿状态#</a><a href='/topic/show?id=5b8055014a9' target=_blank style='color:#2F92EE;'>#投稿#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=55017, encryptionId=fa4e5501ec2, topicName=投稿状态), TopicDto(id=55014, encryptionId=5b8055014a9, topicName=投稿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Wed Dec 08 09:39:59 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513535, encodeId=9214513535ab, content=Required Reviews Completed状态一天今天变成Decision in process,不知结局如何，继续求好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a671625636, createdName=nina2014, createdTime=Wed Jul 15 13:48:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513451, encodeId=8351513451f7, content=请问各位大神，under review 12天后变成 decision in process, 现在已经持续5天了（中间一个周末双休），这状态要持续几天呀？是凶是吉啊？卤煮现在甚是焦躁哇。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05041614884, createdName=ashley1012118, createdTime=Sun Jul 12 23:42:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089503, encodeId=10d7108950371, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089504, encodeId=f947108950474, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973948, encodeId=46b39e39482d, content=请问这个期刊可以共同通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Wed Jun 16 01:58:03 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054187, encodeId=107a105418e73, content=with editor后变成decision in process状态已经8天了，是不是凉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9d85585451, createdName=邪, createdTime=Thu Sep 23 16:30:51 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058774, encodeId=05181058e7452, content=这个杂志的审稿费怎么交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Sat Oct 09 00:04:23 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799866, encodeId=0b00e9986634, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：使用新药治疗9例临床报道，一审3周，大修，第一审稿人提了8个问题，第二审稿人3个问题，一个月修回，2周后接收。审稿人比较客气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Thu Jun 25 22:19:22 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803723, encodeId=13fa803e234c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床研究被BJH，PBC拒稿，投该杂志一个月后小修，录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Tue Jul 21 18:53:14 CST 2020, time=2020-07-21, status=1, ipAttribution=)]

2015-07-15 nina2014

Required Reviews Completed状态一天今天变成Decision in process,不知结局如何，继续求好运

343 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1078015, encodeId=05d510e80156f, content=偏重的研究方向：Meta;血液 经验分享：状态从under review变为Decision in process后多长时间有结果啊，好紧张啊，有没有前辈能回答一下，谢谢<a href='/topic/show?id=fa4e5501ec2' target=_blank style='color:#2F92EE;'>#投稿状态#</a><a href='/topic/show?id=5b8055014a9' target=_blank style='color:#2F92EE;'>#投稿#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=55017, encryptionId=fa4e5501ec2, topicName=投稿状态), TopicDto(id=55014, encryptionId=5b8055014a9, topicName=投稿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Wed Dec 08 09:39:59 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513535, encodeId=9214513535ab, content=Required Reviews Completed状态一天今天变成Decision in process,不知结局如何，继续求好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a671625636, createdName=nina2014, createdTime=Wed Jul 15 13:48:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513451, encodeId=8351513451f7, content=请问各位大神，under review 12天后变成 decision in process, 现在已经持续5天了（中间一个周末双休），这状态要持续几天呀？是凶是吉啊？卤煮现在甚是焦躁哇。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05041614884, createdName=ashley1012118, createdTime=Sun Jul 12 23:42:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089503, encodeId=10d7108950371, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089504, encodeId=f947108950474, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973948, encodeId=46b39e39482d, content=请问这个期刊可以共同通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Wed Jun 16 01:58:03 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054187, encodeId=107a105418e73, content=with editor后变成decision in process状态已经8天了，是不是凉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9d85585451, createdName=邪, createdTime=Thu Sep 23 16:30:51 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058774, encodeId=05181058e7452, content=这个杂志的审稿费怎么交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Sat Oct 09 00:04:23 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799866, encodeId=0b00e9986634, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：使用新药治疗9例临床报道，一审3周，大修，第一审稿人提了8个问题，第二审稿人3个问题，一个月修回，2周后接收。审稿人比较客气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Thu Jun 25 22:19:22 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803723, encodeId=13fa803e234c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床研究被BJH，PBC拒稿，投该杂志一个月后小修，录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Tue Jul 21 18:53:14 CST 2020, time=2020-07-21, status=1, ipAttribution=)]

2015-07-12 ashley1012118

请问各位大神，under review 12天后变成 decision in process, 现在已经持续5天了（中间一个周末双休），这状态要持续几天呀？是凶是吉啊？卤煮现在甚是焦躁哇。。。

357 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1078015, encodeId=05d510e80156f, content=偏重的研究方向：Meta;血液 经验分享：状态从under review变为Decision in process后多长时间有结果啊，好紧张啊，有没有前辈能回答一下，谢谢<a href='/topic/show?id=fa4e5501ec2' target=_blank style='color:#2F92EE;'>#投稿状态#</a><a href='/topic/show?id=5b8055014a9' target=_blank style='color:#2F92EE;'>#投稿#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=55017, encryptionId=fa4e5501ec2, topicName=投稿状态), TopicDto(id=55014, encryptionId=5b8055014a9, topicName=投稿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Wed Dec 08 09:39:59 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513535, encodeId=9214513535ab, content=Required Reviews Completed状态一天今天变成Decision in process,不知结局如何，继续求好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a671625636, createdName=nina2014, createdTime=Wed Jul 15 13:48:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513451, encodeId=8351513451f7, content=请问各位大神，under review 12天后变成 decision in process, 现在已经持续5天了（中间一个周末双休），这状态要持续几天呀？是凶是吉啊？卤煮现在甚是焦躁哇。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05041614884, createdName=ashley1012118, createdTime=Sun Jul 12 23:42:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089503, encodeId=10d7108950371, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089504, encodeId=f947108950474, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973948, encodeId=46b39e39482d, content=请问这个期刊可以共同通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Wed Jun 16 01:58:03 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054187, encodeId=107a105418e73, content=with editor后变成decision in process状态已经8天了，是不是凉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9d85585451, createdName=邪, createdTime=Thu Sep 23 16:30:51 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058774, encodeId=05181058e7452, content=这个杂志的审稿费怎么交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Sat Oct 09 00:04:23 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799866, encodeId=0b00e9986634, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：使用新药治疗9例临床报道，一审3周，大修，第一审稿人提了8个问题，第二审稿人3个问题，一个月修回，2周后接收。审稿人比较客气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Thu Jun 25 22:19:22 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803723, encodeId=13fa803e234c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床研究被BJH，PBC拒稿，投该杂志一个月后小修，录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Tue Jul 21 18:53:14 CST 2020, time=2020-07-21, status=1, ipAttribution=)]

2021-12-28 Mia

选择期刊时应该注意什么？

92 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1078015, encodeId=05d510e80156f, content=偏重的研究方向：Meta;血液 经验分享：状态从under review变为Decision in process后多长时间有结果啊，好紧张啊，有没有前辈能回答一下，谢谢<a href='/topic/show?id=fa4e5501ec2' target=_blank style='color:#2F92EE;'>#投稿状态#</a><a href='/topic/show?id=5b8055014a9' target=_blank style='color:#2F92EE;'>#投稿#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=55017, encryptionId=fa4e5501ec2, topicName=投稿状态), TopicDto(id=55014, encryptionId=5b8055014a9, topicName=投稿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Wed Dec 08 09:39:59 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513535, encodeId=9214513535ab, content=Required Reviews Completed状态一天今天变成Decision in process,不知结局如何，继续求好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a671625636, createdName=nina2014, createdTime=Wed Jul 15 13:48:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513451, encodeId=8351513451f7, content=请问各位大神，under review 12天后变成 decision in process, 现在已经持续5天了（中间一个周末双休），这状态要持续几天呀？是凶是吉啊？卤煮现在甚是焦躁哇。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05041614884, createdName=ashley1012118, createdTime=Sun Jul 12 23:42:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089503, encodeId=10d7108950371, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089504, encodeId=f947108950474, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973948, encodeId=46b39e39482d, content=请问这个期刊可以共同通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Wed Jun 16 01:58:03 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054187, encodeId=107a105418e73, content=with editor后变成decision in process状态已经8天了，是不是凉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9d85585451, createdName=邪, createdTime=Thu Sep 23 16:30:51 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058774, encodeId=05181058e7452, content=这个杂志的审稿费怎么交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Sat Oct 09 00:04:23 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799866, encodeId=0b00e9986634, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：使用新药治疗9例临床报道，一审3周，大修，第一审稿人提了8个问题，第二审稿人3个问题，一个月修回，2周后接收。审稿人比较客气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Thu Jun 25 22:19:22 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803723, encodeId=13fa803e234c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床研究被BJH，PBC拒稿，投该杂志一个月后小修，录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Tue Jul 21 18:53:14 CST 2020, time=2020-07-21, status=1, ipAttribution=)]

2021-12-27 rayms

除文章内容和质量外，选刊时还需注意什么？

94 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1078015, encodeId=05d510e80156f, content=偏重的研究方向：Meta;血液 经验分享：状态从under review变为Decision in process后多长时间有结果啊，好紧张啊，有没有前辈能回答一下，谢谢<a href='/topic/show?id=fa4e5501ec2' target=_blank style='color:#2F92EE;'>#投稿状态#</a><a href='/topic/show?id=5b8055014a9' target=_blank style='color:#2F92EE;'>#投稿#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=55017, encryptionId=fa4e5501ec2, topicName=投稿状态), TopicDto(id=55014, encryptionId=5b8055014a9, topicName=投稿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Wed Dec 08 09:39:59 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513535, encodeId=9214513535ab, content=Required Reviews Completed状态一天今天变成Decision in process,不知结局如何，继续求好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a671625636, createdName=nina2014, createdTime=Wed Jul 15 13:48:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513451, encodeId=8351513451f7, content=请问各位大神，under review 12天后变成 decision in process, 现在已经持续5天了（中间一个周末双休），这状态要持续几天呀？是凶是吉啊？卤煮现在甚是焦躁哇。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05041614884, createdName=ashley1012118, createdTime=Sun Jul 12 23:42:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089503, encodeId=10d7108950371, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089504, encodeId=f947108950474, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973948, encodeId=46b39e39482d, content=请问这个期刊可以共同通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Wed Jun 16 01:58:03 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054187, encodeId=107a105418e73, content=with editor后变成decision in process状态已经8天了，是不是凉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9d85585451, createdName=邪, createdTime=Thu Sep 23 16:30:51 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058774, encodeId=05181058e7452, content=这个杂志的审稿费怎么交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Sat Oct 09 00:04:23 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799866, encodeId=0b00e9986634, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：使用新药治疗9例临床报道，一审3周，大修，第一审稿人提了8个问题，第二审稿人3个问题，一个月修回，2周后接收。审稿人比较客气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Thu Jun 25 22:19:22 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803723, encodeId=13fa803e234c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床研究被BJH，PBC拒稿，投该杂志一个月后小修，录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Tue Jul 21 18:53:14 CST 2020, time=2020-07-21, status=1, ipAttribution=)]

2021-06-16 ms1000002113223257

请问这个期刊可以共同通讯作者吗？

120 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1078015, encodeId=05d510e80156f, content=偏重的研究方向：Meta;血液 经验分享：状态从under review变为Decision in process后多长时间有结果啊，好紧张啊，有没有前辈能回答一下，谢谢<a href='/topic/show?id=fa4e5501ec2' target=_blank style='color:#2F92EE;'>#投稿状态#</a><a href='/topic/show?id=5b8055014a9' target=_blank style='color:#2F92EE;'>#投稿#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=55017, encryptionId=fa4e5501ec2, topicName=投稿状态), TopicDto(id=55014, encryptionId=5b8055014a9, topicName=投稿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Wed Dec 08 09:39:59 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513535, encodeId=9214513535ab, content=Required Reviews Completed状态一天今天变成Decision in process,不知结局如何，继续求好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a671625636, createdName=nina2014, createdTime=Wed Jul 15 13:48:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513451, encodeId=8351513451f7, content=请问各位大神，under review 12天后变成 decision in process, 现在已经持续5天了（中间一个周末双休），这状态要持续几天呀？是凶是吉啊？卤煮现在甚是焦躁哇。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05041614884, createdName=ashley1012118, createdTime=Sun Jul 12 23:42:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089503, encodeId=10d7108950371, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089504, encodeId=f947108950474, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973948, encodeId=46b39e39482d, content=请问这个期刊可以共同通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Wed Jun 16 01:58:03 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054187, encodeId=107a105418e73, content=with editor后变成decision in process状态已经8天了，是不是凉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9d85585451, createdName=邪, createdTime=Thu Sep 23 16:30:51 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058774, encodeId=05181058e7452, content=这个杂志的审稿费怎么交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Sat Oct 09 00:04:23 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799866, encodeId=0b00e9986634, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：使用新药治疗9例临床报道，一审3周，大修，第一审稿人提了8个问题，第二审稿人3个问题，一个月修回，2周后接收。审稿人比较客气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Thu Jun 25 22:19:22 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803723, encodeId=13fa803e234c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床研究被BJH，PBC拒稿，投该杂志一个月后小修，录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Tue Jul 21 18:53:14 CST 2020, time=2020-07-21, status=1, ipAttribution=)]

2021-09-23 邪

with editor后变成decision in process状态已经8天了，是不是凉了

114 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1078015, encodeId=05d510e80156f, content=偏重的研究方向：Meta;血液 经验分享：状态从under review变为Decision in process后多长时间有结果啊，好紧张啊，有没有前辈能回答一下，谢谢<a href='/topic/show?id=fa4e5501ec2' target=_blank style='color:#2F92EE;'>#投稿状态#</a><a href='/topic/show?id=5b8055014a9' target=_blank style='color:#2F92EE;'>#投稿#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=55017, encryptionId=fa4e5501ec2, topicName=投稿状态), TopicDto(id=55014, encryptionId=5b8055014a9, topicName=投稿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Wed Dec 08 09:39:59 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513535, encodeId=9214513535ab, content=Required Reviews Completed状态一天今天变成Decision in process,不知结局如何，继续求好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a671625636, createdName=nina2014, createdTime=Wed Jul 15 13:48:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513451, encodeId=8351513451f7, content=请问各位大神，under review 12天后变成 decision in process, 现在已经持续5天了（中间一个周末双休），这状态要持续几天呀？是凶是吉啊？卤煮现在甚是焦躁哇。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05041614884, createdName=ashley1012118, createdTime=Sun Jul 12 23:42:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089503, encodeId=10d7108950371, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089504, encodeId=f947108950474, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973948, encodeId=46b39e39482d, content=请问这个期刊可以共同通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Wed Jun 16 01:58:03 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054187, encodeId=107a105418e73, content=with editor后变成decision in process状态已经8天了，是不是凉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9d85585451, createdName=邪, createdTime=Thu Sep 23 16:30:51 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058774, encodeId=05181058e7452, content=这个杂志的审稿费怎么交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Sat Oct 09 00:04:23 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799866, encodeId=0b00e9986634, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：使用新药治疗9例临床报道，一审3周，大修，第一审稿人提了8个问题，第二审稿人3个问题，一个月修回，2周后接收。审稿人比较客气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Thu Jun 25 22:19:22 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803723, encodeId=13fa803e234c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床研究被BJH，PBC拒稿，投该杂志一个月后小修，录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Tue Jul 21 18:53:14 CST 2020, time=2020-07-21, status=1, ipAttribution=)]

2021-10-09 1801fe6feam

这个杂志的审稿费怎么交？

104 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1078015, encodeId=05d510e80156f, content=偏重的研究方向：Meta;血液 经验分享：状态从under review变为Decision in process后多长时间有结果啊，好紧张啊，有没有前辈能回答一下，谢谢<a href='/topic/show?id=fa4e5501ec2' target=_blank style='color:#2F92EE;'>#投稿状态#</a><a href='/topic/show?id=5b8055014a9' target=_blank style='color:#2F92EE;'>#投稿#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=55017, encryptionId=fa4e5501ec2, topicName=投稿状态), TopicDto(id=55014, encryptionId=5b8055014a9, topicName=投稿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Wed Dec 08 09:39:59 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513535, encodeId=9214513535ab, content=Required Reviews Completed状态一天今天变成Decision in process,不知结局如何，继续求好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a671625636, createdName=nina2014, createdTime=Wed Jul 15 13:48:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513451, encodeId=8351513451f7, content=请问各位大神，under review 12天后变成 decision in process, 现在已经持续5天了（中间一个周末双休），这状态要持续几天呀？是凶是吉啊？卤煮现在甚是焦躁哇。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05041614884, createdName=ashley1012118, createdTime=Sun Jul 12 23:42:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089503, encodeId=10d7108950371, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089504, encodeId=f947108950474, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973948, encodeId=46b39e39482d, content=请问这个期刊可以共同通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Wed Jun 16 01:58:03 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054187, encodeId=107a105418e73, content=with editor后变成decision in process状态已经8天了，是不是凉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9d85585451, createdName=邪, createdTime=Thu Sep 23 16:30:51 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058774, encodeId=05181058e7452, content=这个杂志的审稿费怎么交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Sat Oct 09 00:04:23 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799866, encodeId=0b00e9986634, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：使用新药治疗9例临床报道，一审3周，大修，第一审稿人提了8个问题，第二审稿人3个问题，一个月修回，2周后接收。审稿人比较客气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Thu Jun 25 22:19:22 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803723, encodeId=13fa803e234c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床研究被BJH，PBC拒稿，投该杂志一个月后小修，录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Tue Jul 21 18:53:14 CST 2020, time=2020-07-21, status=1, ipAttribution=)]

2020-06-25 syweiang

审稿速度:1.0 | 投稿命中率:75.0
经验分享：使用新药治疗9例临床报道，一审3周，大修，第一审稿人提了8个问题，第二审稿人3个问题，一个月修回，2周后接收。审稿人比较客气。

160 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1078015, encodeId=05d510e80156f, content=偏重的研究方向：Meta;血液 经验分享：状态从under review变为Decision in process后多长时间有结果啊，好紧张啊，有没有前辈能回答一下，谢谢<a href='/topic/show?id=fa4e5501ec2' target=_blank style='color:#2F92EE;'>#投稿状态#</a><a href='/topic/show?id=5b8055014a9' target=_blank style='color:#2F92EE;'>#投稿#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=55017, encryptionId=fa4e5501ec2, topicName=投稿状态), TopicDto(id=55014, encryptionId=5b8055014a9, topicName=投稿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Wed Dec 08 09:39:59 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513535, encodeId=9214513535ab, content=Required Reviews Completed状态一天今天变成Decision in process,不知结局如何，继续求好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a671625636, createdName=nina2014, createdTime=Wed Jul 15 13:48:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513451, encodeId=8351513451f7, content=请问各位大神，under review 12天后变成 decision in process, 现在已经持续5天了（中间一个周末双休），这状态要持续几天呀？是凶是吉啊？卤煮现在甚是焦躁哇。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05041614884, createdName=ashley1012118, createdTime=Sun Jul 12 23:42:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089503, encodeId=10d7108950371, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089504, encodeId=f947108950474, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973948, encodeId=46b39e39482d, content=请问这个期刊可以共同通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Wed Jun 16 01:58:03 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054187, encodeId=107a105418e73, content=with editor后变成decision in process状态已经8天了，是不是凉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9d85585451, createdName=邪, createdTime=Thu Sep 23 16:30:51 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058774, encodeId=05181058e7452, content=这个杂志的审稿费怎么交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da752138828, createdName=1801fe6feam, createdTime=Sat Oct 09 00:04:23 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799866, encodeId=0b00e9986634, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：使用新药治疗9例临床报道，一审3周，大修，第一审稿人提了8个问题，第二审稿人3个问题，一个月修回，2周后接收。审稿人比较客气。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Thu Jun 25 22:19:22 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803723, encodeId=13fa803e234c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床研究被BJH，PBC拒稿，投该杂志一个月后小修，录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Tue Jul 21 18:53:14 CST 2020, time=2020-07-21, status=1, ipAttribution=)]

2020-07-21 syweiang

审稿速度:1.0 | 投稿命中率:50.0
经验分享：临床研究被BJH，PBC拒稿，投该杂志一个月后小修，录用

180 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务